Zum Inhalt springen

Neutral packaging, no branding

Produktbild folgt

Rezeptorliganden · Ipamorelin

Ipamorelin

Five amino acids, one receptor target.

  • Pentapeptide: Aib-His-D-2-Nal-D-Phe-Lys-NH2
  • Selective agonist at the ghrelin receptor GHS-R1a
  • Status: in preparation — release pending analytical testing

Price per vial

45,00 €

incl. 19% VAT · Shipping

Quantity

1

3 vials 3% off, 5 vials 5%, 10 vials 10% — pro rata in between

In preparationShips from Germany

Shipping

Free with code

DHL

Payment

Bank transfer in advance

Account

Not required

SELECTIVE

Pentapeptide at the ghrelin receptor. Studied in the context of the somatotropic axis.

Research field

What this is.

Ipamorelin is a synthetic pentapeptide belonging to the class of growth hormone secretagogues and was derived from the GHRP series. The literature describes the compound as a selective agonist at the ghrelin receptor, the growth hormone secretagogue receptor 1a (GHS-R1a). In preclinical research it is studied in the context of the somatotropic axis, that is, the regulation of growth hormone release from the pituitary gland. A recurring subject of studies is its selectivity profile compared with older secretagogues of the same class. KILUK supplies Ipamorelin exclusively as reference and research material for in vitro and preclinical work.

Ghrelin receptorGHS-R1aReceptor ligandsSomatotropic axisPentapeptidePreclinical research

Specification

Data, not adjectives.

Scientific designation
Ipamorelin (NNC 26-0161)
Sequence
Aib-His-D-2-Nal-D-Phe-Lys-NH2
Molecular formula
C38H49N9O5
Molar mass
711.86 g/mol
CAS number
170851-70-4
Form / packaging
Lyophilised powder, 5 mg per vial
Availability
In preparation — release pending analytical testing

Storage

Store the lyophilised powder dry and protected from light. At 2–8 °C for short periods, at −20 °C for longer storage. Avoid repeated temperature changes. Shipping takes place without a cold chain at ambient temperature: the dry lyophilised powder is stable over the shipping period and transit times are short.

Handling in the lab

Handling under laboratory conditions only. Allow the vial to reach room temperature before opening so that no condensate settles on the lyophilised powder. Wear standard protective equipment (gloves, safety glasses, lab coat) and avoid generating aerosols when opening. Dispose of in accordance with the applicable laboratory regulations. KILUK does not provide instructions for use or dosage.

From the lab to you

Every batch takes the same route.

Four steps, none of them optional.

01

Synthese

Festphasensynthese, anschließend Aufreinigung.

02

Analyse

Reinheitsbestimmung im Labor.

03

Identität

Massenspektrometrische Bestätigung der Molmasse.

04

Charge

Chargennummer auf Etikett, Dokumentation im Haus.

Common questions

Ipamorelin

A synthetic pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 (CAS 170851-70-4) from the class of growth hormone secretagogues. KILUK supplies it as reference and research material.

The ghrelin receptor GHS-R1a. Ipamorelin is described in the literature as a selective agonist at this receptor and is associated with research into the somatotropic axis.

It is not linked on the product page and is not included with the delivery. We send it on request by email, quoting the batch number; the batch number is printed on the vial label.

Dry and protected from light: at 2–8 °C for short periods, at −20 °C for longer storage. Avoid repeated temperature changes.

Not yet. The item is listed in the catalogue as in preparation and cannot be ordered. KILUK does not accept pre-orders; on this page you can sign up to be notified.

Sold exclusively to persons aged 18 or over for use in laboratory, educational and research settings. The material is not supplied for use in humans or animals.

Legal notice

Research chemical. Intended exclusively for laboratory and research purposes. Not for human or animal consumption, not for use in humans or animals. Not a medicinal product, not a food, not a dietary supplement, not a cosmetic. KILUK gives no dosage or usage recommendations and makes no statements regarding any effect in humans. Sold exclusively to persons aged 18 or over for use in laboratory, educational and research settings.